Should you buy Aemetis stock now?
No, the technical signal for Aemetis is currently SELL. Aemetis trades at $1.69 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.079 with rising momentum (signal: -0.096); RSI is at 45.0 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $13.88 points to 721.3% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Aemetis stock?
The average analyst price target for Aemetis is $13.88. The current price is $1.69, which gives an upside of 721.3%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $12.49 and $15.27.
Is Aemetis a dividend stock?
No, Aemetis does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Aemetis stock?
Aemetis is rated as a stock with extreme risk. the annual standard deviation is 97.4%, which classifies the stock as extreme risk.
Is Aemetis overvalued?
No, Aemetis is considered undervalued based on the analyst price target (721.3% upside). Aemetis has the following valuation ratios: a P/S ratio of 0.5, a P/B ratio of 141.5. The analyst price target suggests that the stock is undervalued by 721.3%.
Is Aemetis overbought?
No, Aemetis is not overbought. RSI is at 45.0 (neutral zone). The technical indicators show: RSI is at 45.0 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 6.5% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Aemetis earnings report?
Aemetis reports earnings TODAY, August 6, 2026! The stock currently trades at $1.69. Watch how the price reacts after the release.
Is Aemetis shorted?
Yes, Aemetis is shorted with 11.5% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Aemetis stock?
No, insiders are not buying Aemetis shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 1 sales. On a net basis, 20,500 $ worth of shares were sold. Across the last 20 reported transactions, the split is 12 purchases and 8 sales, with a net 843,622 $ bought. Active sellers include Simon Timothy Alan, BARTON FRANCIS P, BLOCK JOHN R and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Aemetis a good stock?
Based on our total score, Aemetis is rated as a disastrous stock with a total score of 17 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 26/100, Quality: 15/100, Momentum: 9/100. In addition: analysts see 721.3% upside to the price target; technical signal: Strong Sell. Whether Aemetis is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Aemetis stock?
The outlook for Aemetis based on current data: the average analyst price target is $13.88 (+721.3%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/6/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Aemetis stock rising?
Aemetis is rising right now. The technical indicators show: the price is 6.5% above the 20-day average; short interest is 11.5% (high – many are betting on a decline); insiders have mostly been buying the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Aemetis go?
The average analyst price target for Aemetis is $13.88, which corresponds to a potential gain of 721.3% from the current price of $1.69. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Aemetis fall?
We lack enough history to give a specific floor for Aemetis. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Aemetis do?
Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. The company operates through California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel segments. It engages in the operation, acquisition, development, and commercialization of... The company belongs to the Materialer sector, more specifically the Specialkemi industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Aemetis as an investment.
Did Aemetis raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Aemetis. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Aemetis making money or losing money?
No, Aemetis is currently not making money — the company is losing money with a negative profit margin of -33.8%, a substantial loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Aemetis go bankrupt?
The bankruptcy risk of Aemetis is rated as elevated. Altman Z2 (a model for assessing financial distress) is -18.00 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 4 — which is average. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Aemetis have a lot of debt?
Yes, Aemetis has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the materialer sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
